When depression has not improved after multiple medications, the next decision can feel unusually heavy. For many people weighing ect vs spravato vs tms, the real question is not which treatment sounds most advanced – it is which one makes the most clinical sense for their symptoms, history, safety needs, and daily life.
Treatment-resistant depression often requires a different level of care. That does not mean hope is running out. It means the treatment plan may need to move beyond standard antidepressants and toward evidence-based interventions that work in different ways.
ECT vs Spravato vs TMS: the core differences
Although these three treatments are often grouped together, they are not interchangeable. ECT, or electroconvulsive therapy, uses a carefully controlled electrical stimulus under anesthesia to trigger a brief therapeutic seizure. TMS, or transcranial magnetic stimulation, uses targeted magnetic pulses to stimulate specific brain regions involved in mood regulation. Spravato, the brand name for intranasal esketamine, works through glutamate signaling and is given in a monitored medical setting.
That difference matters because each option has a distinct role. ECT is generally considered the most powerful and fastest-acting option for severe depression, especially when symptoms include suicidality, psychosis, catatonia, or profound functional decline. TMS is a noninvasive, FDA-cleared therapy that can be a strong option for patients who want to avoid anesthesia and return to normal activities right after treatment. Spravato can be a meaningful choice for adults with treatment-resistant depression who need a different medication pathway than traditional oral antidepressants.
How ECT works and when it is used
ECT has been used for decades and remains one of the most effective treatments in psychiatry for severe major depression. It is usually considered when symptoms are urgent, disabling, or unresponsive to multiple prior treatments. In some cases, it is also used when a patient cannot wait several weeks for improvement.
The treatment is done under general anesthesia with muscle relaxation, so the patient does not feel the procedure itself. A course of ECT is usually given several times per week over a few weeks, followed by maintenance treatment for some individuals.
Its biggest strength is effectiveness, particularly in severe or life-threatening depression. The trade-off is that it is more medically involved than TMS or Spravato. It requires anesthesia, transportation support, and recovery time. Some patients also experience short-term confusion or memory problems, which can be mild for some people and more disruptive for others. For that reason, ECT is often chosen when the likely benefits clearly outweigh those drawbacks.
How TMS works and what patients often like about it
TMS uses magnetic pulses to stimulate the left dorsolateral prefrontal cortex, an area commonly involved in depression. Unlike ECT, it does not require anesthesia and does not induce a seizure. Patients remain awake during treatment and can usually drive themselves to and from appointments.
A standard course involves frequent sessions over several weeks. That time commitment can be substantial, but many patients appreciate how manageable the treatment feels day to day. The most common side effects are scalp discomfort or headache, especially early in the course, and these are often temporary.
TMS tends to be especially appealing for people who want a non-drug option or who have had difficulty tolerating antidepressant side effects. It is also often considered when depression is persistent but not acutely life-threatening. The limitation is that improvement may be gradual, and while many patients benefit, TMS is not the best fit for every clinical picture. For example, if someone is severely suicidal, psychotic, or unable to function at a basic level, a faster-acting intervention may be more appropriate.
At Brainiac Behavioral Health, TMS therapy is offered in Anaheim Hills as part of a broader interventional psychiatry approach, which can be important for patients who need more than a one-size-fits-all depression plan.
How Spravato differs from both ECT and TMS
Spravato is not a standard antidepressant, and it is not simply a stronger version of one. It is esketamine, a medication related to ketamine, delivered as a nasal spray under medical supervision. It is FDA-approved for adults with treatment-resistant depression and for certain adults with major depressive disorder and acute suicidal thoughts or behavior, depending on the clinical context and treatment plan.
Because Spravato can cause dissociation, sedation, dizziness, increased blood pressure, and temporary impairment, it must be given in a certified medical setting with post-treatment monitoring. Patients need someone else to drive them home after each session.
What patients often appreciate is that Spravato may help when multiple antidepressants have failed and may work through a very different biological pathway. Some people notice improvement relatively quickly. Others need time and dose adjustments within the treatment framework. As with any treatment, response varies.
One practical consideration is that Spravato is typically used alongside an oral antidepressant rather than fully replacing medication treatment. For some patients, that is fine. For others hoping to move away from medication altogether, TMS may feel more aligned with their preferences.
ECT vs Spravato vs TMS for different kinds of depression
The best option often depends on the type and severity of depression, not just the diagnosis label.
For severe depression with psychosis, catatonia, profound weight loss, refusal to eat, or urgent suicidality, ECT is often the strongest consideration because of its high effectiveness and speed. When symptoms are entrenched but the patient is medically stable and wants a noninvasive treatment with minimal downtime, TMS is often a reasonable next step. When a patient has failed several medications and wants an evidence-based option that works differently from typical antidepressants, Spravato may be a strong fit.
This is why careful psychiatric evaluation matters. Two people can both have treatment-resistant depression and still need very different recommendations. One may need the speed and intensity of ECT. Another may benefit from the structure and tolerability of TMS. A third may be best served by Spravato combined with ongoing medication management and psychotherapy.
What about side effects, safety, and convenience?
This is where the decision often becomes more personal.
ECT is the most intensive option from a medical and logistical standpoint. It requires anesthesia and can affect short-term memory. But when depression is severe enough, those limitations may be acceptable in exchange for a treatment with a strong track record.
TMS is often the easiest to integrate into daily life. Patients are awake, there is no anesthesia, and cognitive side effects are not expected in the way they can be with ECT. The challenge is the visit schedule. It asks for consistency over time.
Spravato falls somewhere in the middle. It does not involve anesthesia or a seizure, but it does require in-office monitoring after each treatment and no driving until the next day. Some patients find the monitored structure reassuring. Others find it disruptive.
Which treatment is most effective?
There is no single ranking that applies to every patient, but broad patterns do exist. ECT is generally viewed as the most effective option for severe major depression, particularly in urgent or complicated cases. TMS and Spravato are both valuable, evidence-based treatments for treatment-resistant depression, but they serve somewhat different patient needs and treatment goals.
Effectiveness is also not just about symptom reduction on paper. It includes how quickly someone needs relief, what side effects are acceptable, what medical risks are present, and what kind of treatment burden they can realistically manage. A treatment that is excellent in theory may not be the best treatment if a patient cannot tolerate it or complete the full course.
How to choose the next step with confidence
If you are comparing ect vs spravato vs tms, it helps to think less in terms of best overall and more in terms of best fit. The right choice usually comes from a full psychiatric assessment that looks at prior medication trials, current symptom severity, co-occurring anxiety or mood symptoms, safety concerns, medical history, and practical realities such as transportation and schedule.
For patients in Orange County considering interventional treatment, location can matter too. TMS is available in Anaheim Hills, while Spravato is available in Orange and Anaheim Hills, which may affect what is easiest to continue consistently.
The most helpful next step is often a conversation with a psychiatrist who regularly evaluates treatment-resistant depression and can explain not only what each treatment is, but why one may fit your situation better than another. When depression has been persistent, clarity itself can feel relieving. The right plan should do more than offer another option – it should restore balance, clarity, and hope.